SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination

Lancet. 2021 Sep 18;398(10305):1041-1042. doi: 10.1016/S0140-6736(21)01891-2. Epub 2021 Aug 17.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • SARS-CoV-2*
  • Vaccination

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine